Kardigan, Inc.

NASDAQ:KARD

Biotechnology

Healthcare
$12.32 +3.50%

+$0.77 today

Market cap
$1.10B
Beta
0.00
52W Low $16.25High $24.00

Volume 0.55M

Average 5.84M

KARD Other Financing Activities

Financing cash flows not reported separately.

No reported Other Financing Activities figures are available to summarize.

Other Financing Activities history

Currency unavailable · from the cash flow

No Other Financing Activities data reported for this period type.

Other Financing Activities vs competitors

How KARD compares with its peers on the latest reported figures

KARD Competitors
Other Financing Activities for KARD and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CYTKCytokinetics, IncorporatedLTM Jun 2026$79.48M USD-208.4%—112.0%
RNAAtrium Therapeutics, Inc.FY2025$42.57M USD——228.7%
TNYATenaya Therapeutics, Inc.LTM Mar 2026$415K USD——184.4%
IKTInhibikase Therapeutics, Inc.LTM Mar 2026$31.62K USD+3.3%——
NAMSNewAmsterdam Pharma Company N.V.LTM Jun 2026$0 USD-100.0%—0.0%
KARDKardigan, Inc.—— ———
Peer median (excluding KARD) —-100.0%—148.2%

Competitors are the stored peer set for KARD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Kardigan, Inc.

NASDAQ:KARD

Intrinsic Alpha fair value

Locked

Current Price

$12.32

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.